rxstat › Shortages › Doxepin
Doxepin shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Doxepin products are in shortage in Canada (1 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Mar 10, 2017
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-DOXEPIN
150MG · CAPSULE · APOTEX INC
DIN 02050056 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
25MG · CAPSULE · AA PHARMA INC
DIN 00024333 · ended Dec 16, 2025 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
75MG · CAPSULE · AA PHARMA INC
DIN 00400750 · ended Dec 16, 2025 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
25MG · CAPSULE · AA PHARMA INC
DIN 00024333 · ended Sep 16, 2025 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
100MG · CAPSULE · AA PHARMA INC
DIN 00326925 · ended Sep 16, 2025 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
10MG · CAPSULE · AA PHARMA INC
DIN 00024325 · ended Jan 15, 2025 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
10MG · CAPSULE · AA PHARMA INC
DIN 00024325 · ended Sep 4, 2024 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
10MG · CAPSULE · AA PHARMA INC
DIN 00024325 · ended Apr 28, 2023 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
10MG · CAPSULE · AA PHARMA INC
DIN 00024325 · ended Nov 28, 2022 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
75MG · CAPSULE · AA PHARMA INC
DIN 00400750 · ended Nov 28, 2022 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
25MG · CAPSULE · AA PHARMA INC
DIN 00024333 · ended Nov 28, 2022 · Disruption of the manufacture of the drug.
ResolvedSINEQUAN
50MG · CAPSULE · AA PHARMA INC
DIN 00024341 · ended Nov 28, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 26 reports. All reports are on file with Health Canada.
What's happening
Doxepin is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Doxepin is classified under “ANTIDEPRESSANTS” (ATC N06AA).
Recent changes
Common questions
When will Doxepin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Doxepin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.